Potassium balance in dialysis patients

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Potassium balance is a persistent challenge in end-stage renal disease (ESRD) patients undergoing dialysis.
• Hyperkalemia is more prevalent than hypokalemia in dialysis patients and is linked to increased mortality.
• Suboptimal adherence to low-potassium diets and medication effects complicate potassium management.

Purpose of the Study:

• To review the challenges and current strategies for managing hyperkalemia in ESRD patients.
• To highlight the risks associated with both hyperkalemia and overly aggressive potassium reduction during dialysis.
• To discuss potential future therapeutic options for improving potassium control.

Main Methods:

• Review of existing literature on potassium management in dialysis patients.
• Analysis of the impact of dialysis bath composition on serum potassium levels.
• Evaluation of the role of diet, medications, and emerging therapies.

Main Results:

• Dialysis bath modifications can lower predialysis potassium, but very low potassium baths (<2 mEq/l) increase sudden cardiac death risk.
• Despite awareness, patient adherence to low-potassium diets remains suboptimal.
• Certain medications (ACE inhibitors, ARBs, spironolactone) can elevate potassium levels, necessitating closer monitoring.

Conclusions:

• Managing hyperkalemia in ESRD requires balancing the risks of high potassium with the dangers of overly restrictive dialysis.
• Frequent hemodialysis and prophylactic implantable cardioverter-defibrillators are potential avenues for improving outcomes.
• Further research is needed to optimize interdialytic potassium control and reduce associated mortality.